Leukocyte count in peripheral arterial disease: A simple, reliable, inexpensive approach to cardiovascular risk

Giuseppe Giugliano1, Gregorio Brevetti, Simona Lanero

  • 1Department of Clinical Medicine and Cardiovascular and Immunological Sciences, University of Naples Federico II, via Pansini 5, 80131 Naples, Italy.

Atherosclerosis
|December 8, 2009
PubMed

Insights

Elevated total leukocyte count (TLC) and neutrophil count (NC) predict major cardiovascular events in peripheral arterial disease (PAD). These simple blood tests improve risk prediction when combined with the ankle-brachial index (ABI).

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Vascular Disease Research

Background:

  • Elevated leukocyte count is a known cardiovascular risk predictor in general and coronary populations.
  • The prognostic significance of leukocyte count in peripheral arterial disease (PAD) remains under-investigated.

Purpose of the Study:

  • To evaluate the impact of leukocyte count on major cardiovascular event incidence in PAD patients.
  • To determine if leukocyte count enhances the prognostic capability of the ankle-brachial index (ABI).

Main Methods:

  • Prospective assessment of myocardial infarction and stroke in 259 consecutive PAD patients.
  • Utilized Receiver-Operating Characteristic (ROC) analysis and bootstrap methods for outcome prediction cut-offs.
  • Employed hazard ratios (HRs) and c-statistics to evaluate risk classification accuracy.

Main Results:

  • Total leukocyte count (TLC) and neutrophil count (NC) were independently associated with increased cardiovascular risk (HR=1.35 and HR=1.31, respectively).
  • Patients with low ABI (< or = 0.63) and high TLC (>7.7 x10^9/L) or NC (>4.6 x10^9/L) faced a five-fold increased risk.
  • Combining ABI with TLC or NC significantly improved prognostic prediction (c-statistics 0.70 and 0.69) compared to ABI alone (0.61).

Conclusions:

  • Inexpensive and reliable TLC and NC tests predict major cardiovascular events in PAD patients.
  • Leukocyte counts significantly add to the prognostic power of the ankle-brachial index (ABI) in PAD.
  • TLC and NC represent valuable, accessible tools for risk stratification in peripheral arterial disease.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...